...Haitao Zhang; Xin Yang; Fangfang Zheng; Suhua Wan; Yingying Xu Introduction: The aim of this study was to compare the changes in serum concentrations of vascular endothelial growth factor (VEGF)-A and B after intravitreal injection of ranibizumab (IVR) or conbercept (IVC) for retinopathy...

... and July 2022. All study eyes had persistent residual retinal fluid after receiving at least 3 intravitreal injections of other anti-VEGF agents prior to switch to brolucizumab. Results: Among 66 eyes from 60 patients (35 males; mean age 76.5 ± 7.4 years) with nAMD, 43 (65.2%) eyes received a complete...

... plots of postoperative 1-month BCVA. Note: Subgroup analysis by type of adjuvant intravitreal injections, including DXI and TAI. Fig. 3. a Forest plots of postoperative 3-month CMT. b Forest plots of postoperative 3-month BCVA. Note: Subgroup analysis by type of adjuvant intravitreal...

... Aflibercept Intravitreal injection Endophthalmitis Intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents are currently the first-line therapy for various retinal diseases, including neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), since common...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Endophthalmitis Intravitreal injection Vascular endothelial growth factor The use of intravitreal anti-vascular endothelial growth factor (VEGF) agents has...

... to intravitreal injections (IVIs) were compared to those without ACP. Methods: Neovascular age-related macular degeneration (nAMD) was treated in a pro re nata regimen with a minimum of 9 IVIs. RNFLT change was determined in spectral domain optical coherence tomography. Results: In 32 patients without ACP, mean...

... surgery. The most common side effect of DEX implant, the increased IOP [ 25 ], was well controlled by local antiglaucomatous therapy with one up to three agents. No endophthalmitis or iatrogenic retinal detachment could be observed. Intravitreal injection of a DEX implant can be considered as an adequate...

.... Intraocular pressure Anti-VEGF Aflibercept Intravitreal injection Age-related macular degeneration Intravitreal injection (IVI) is a route of administration that has been expanding since anti-VEGF agent approval in the treatment of wet age-related macular degeneration (ARMD). The indications...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Diabetic macular edema Intravitreal injection Ranibizumab Bevacizumab...

... incidences since the introduction of anti-vascular endothelial growth factor (anti-VEGF) therapies as well as a temporal association between the tear event and the intravitreal injection. As the number of AMD patients and the number of administered anti-VEGF injections increase, both the challenge of RPE...

... for the development of increased IOP. Materials and Methods: This prospective study included a total of 106 eyes receiving intravitreal injection of bevacizumab as treatment for macular edema or active choroidal neovascularization. IOP was measured by Goldmann applanation tonometry immediately before the intravitreal...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Corticosteroids Dexamethasone implant Intravitreal injection Ozurdex...

...Paolo Lanzetta; Frank Holz; Jordi Monés; Giuseppe Querques; Paulo Stanga; Daniele Veritti; Fabio Barbone; Silvio Brusaferro; Miriam Isola Purpose: To perform a risk mitigation review of intravitreal injections. Methods: A pan-European expert team conducted a healthcare failure modes and effects...

...Maiko Inoue; Shinichiro Kobayakawa; Chie Sotozono; Hideki Komori; Kumiko Tanaka; Yuzo Suda; Hiroyuki Matsushima; Shigeru Kinoshita; Tadashi Senoo; Tetsuo Tochikubo; Kazuaki Kadonosono Aims: To report the incidence of infectious and noninfectious endophthalmitis after intravitreal injection of anti...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Retinal vein occlusion Laser treatment Intravitreal injection Antiangiogenic drug Ranibizumab Bevacizumab Pegaptanib sodium Vascular endothelial growth factor trap Steroids...

...-month follow-up period. Short-term results are promising, but further studies are necessary to evaluate long-term efficacy. Polypoidal choroidal vasculopathy Choroidal neovascularization Vascular endothelial growth factor Bevacizumab Intravitreal injection Polypoidal choroidal...

..., instructions or products referred to in the content or advertisements. Angioid streaks Bevacizumab Choroidal neovascularization Intravitreal injection The natural prognosis of choroidal neovascularization (CNV) associated with angioid streaks (AS) is very poor because the macula is involved...

.... Intravitreal injection Choroidal neovascularization Age-related macular degeneration Reinjection Visual acuity, computer-based tests Vascular endothelial growth factor inhibitors Central visual acuity (VA) in patients with vascular age-related macular degeneration (AMD) can improve significantly...

... modalities with focal or grid argon laser photocoagulation, pars plana vitrectomy with and without peeling of the inner limiting membrane (ILM), as well as intravitreal injections using triamcinolone acetonide or novel vascular endothelial growth factor (VEGF) inhibitors are described. Results: DME results...

...Martina T. Kralinger; Gerhard F. Kieselbach; Monika Voigt; Brandy Hayden; Eleut Hernandez; Viviana Fernandez; Jean-Marie Parel Background: The intravitreal injection of dispase has been shown to be a valuable method for induction of experimental PVR. The goal of the present study was to gain...